ABOUT ME
I'm Yvanka Gilliam
MBA, PharmD
Yvanka Gilliam, MBA, PharmD is an accomplished global executive with expertise in International business strategy and business development. She has a track record of extensive business growth with short and long term vision in executing business objectives that gain traction, drive momentum and improve business efficiency. Yvanka has a career-long history as an innovative, high-impact, results-driven executive specializing in the successful launch of oncology products in the Unites States and Emerging markets. She has extensive experience within the pharmaceutical, biotechnology, diagnostics, CRO, and the consulting industries for well over 20 years. Her expertise is in International business with a strong focus on the extension of products and services in the Asia Pacific, Middle East, and Africa regions. She is a dynamic and enthusiastic leader with the ability to build consensus and alignment among internal and external stakeholders she is also a trusted advisor, skilled in leading operational strategy, business development and medical affairs, providing a therapeutic perspective to influence commercial growth.
SPECIALTIES
Oncology and Diagnostics with a focus on Thoracic and GI/GU Malignancies and Rare Diseases.
INTERESTS
Biotechnology, Pharmaceutical, Diagnostic, Device, Genetic testing, Consulting Companies, and CROs
TARGET REGIONS
Emerging Markets in the Asia Pacific, Middle East, and Africa regions.
Executive Summary
Currently serves as the Vice President for Asia Pacific, Middle East, and Africa at Diaceutics, which offers the world’s first diagnostic commercialization platform for precision medicine – DXRX, The Diagnostic Network®. She has successfully leveraged her clinical background and expertise in business development, commercial growth, and innovation to deliver a 150%+ revenue increase in the region, with APAC contributing 25% of total global revenue.
Business Strategy
The power in driving swift and sustainable business growth, and profitability lies in intersecting her clinical background, expertise in international business and operational leadership. That strategy has driven Yvanka to succeed in expanding companies into emerging markets and verticals, transforming business models, building out lean operations, and pioneering new offerings.
Product & Client Strategies
Yvanka has a track record for strong business acumen and client management through innovation and a patient-centric approach to commercializing cutting-edge products and services. Serving as a strategic and collaborative partner to clients, she swiftly identifies how to best meet their needs and translate their business priorities, challenges, and initiatives into win-win solutions. Yvanka effectively communicates the unique value proposition of products and services while maximizing market penetration, product uptake, and utilization.
Early
Career
Senior Medical Science Liaison, Thoracic Cancer-Immuno-Oncology
AstraZeneca Pharmaceutical Corporation – Gaithersburg, MD, US (Sep 2015 – Sep 2017)
Associate Director, Field-Based Medical Affairs – Oncology
Boehringer Ingelheim Pharmaceuticals, Inc. – Ridgefield, CT, US (Mar 2010 – Sep 2015)
Senior Medical Science Liaison
Millennium Pharmaceutical Company – Cambridge, MA, US (Mar 2005 – Feb 2010)
Manager, Professional Medical Education
Aventis Pharmaceutical Company – Bridgewater, NJ, US (Sep 2004 – Mar 2005)
Associate Marketing Manager
Eli Lilly Pharmaceutical Company – Indianapolis, IN, US (Jun 2000 – Aug 2004)
Associate Marketing Manager
Executive Oncology Business Development Specialist │ Senior Clinical Project Manager